The major drug classes currently used in PD treatment include dopamine precursors, dopamine agonists (DA), DDC inhibitors, COMT inhibitors, anticholinergics, and N-methyl-D-aspartate (NMDA) antagonists [8]. The gene discussed is COMT; the disease is Parkinson disease.